5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
D000212:Acyclovir; D000818:Animals; D001087:Arabinonucleosides / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D002460:Cell Line; D003857:Deoxyuridine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004790:Enzyme Induction; D006147:Guanine / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D009154:Mutation; D010746:Phosphonoacetic Acid / Q000494:pharmacology; D018139:Simplexvirus / Q000187:drug effects* / Q000235:genetics; D013936:Thymidine / Q000031:analogs & derivatives / Q000494:pharmacology; D013937:Thymidine Kinase / Q000096:biosynthesis
D001087:Arabinonucleosides; C020235:brivudine; C024722:5-methoxymethyl-2'-deoxyuridine; D006147:Guanine; D013937:Thymidine Kinase; D001973:Bromodeoxyuridine; D010746:Phosphonoacetic Acid; C010032:thymine arabinoside; D013936:Thymidine; D003857:Deoxyuridine; D000212:Acyclovir